147 related articles for article (PubMed ID: 11579300)
1. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants.
Staatz CE; Taylor PJ; Lynch SV; Willis C; Charles BG; Tett SE
Transplantation; 2001 Sep; 72(6):1056-61. PubMed ID: 11579300
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
Staatz CE; Tett SE
Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
[TBL] [Abstract][Full Text] [Related]
5. Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy.
García Sánchez MJ; Manzanares C; Santos-Buelga D; Blázquez A; Manzanares J; Urruzuno P; Medina E
Clin Pharmacokinet; 2001 Jan; 40(1):63-71. PubMed ID: 11236810
[TBL] [Abstract][Full Text] [Related]
6. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
Sam WJ; Aw M; Quak SH; Lim SM; Charles BG; Chan SY; Ho PC
Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
Fukudo M; Yano I; Masuda S; Goto M; Uesugi M; Katsura T; Ogura Y; Oike F; Takada Y; Egawa H; Uemoto S; Inui K
Clin Pharmacol Ther; 2006 Oct; 80(4):331-45. PubMed ID: 17015051
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
Zahir H; McLachlan AJ; Nelson A; McCaughan G; Gleeson M; Akhlaghi F
Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097
[TBL] [Abstract][Full Text] [Related]
11. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation.
Fukatsu S; Yano I; Igarashi T; Hashida T; Takayanagi K; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K; Tanaka K; Inui K
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):479-84. PubMed ID: 11699612
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
[TBL] [Abstract][Full Text] [Related]
15. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients].
Zhang GM; Li L; Chen WQ; Bi SS; Liu X; Zhang XL; Lu W
Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
Antignac M; Hulot JS; Boleslawski E; Hannoun L; Touitou Y; Farinotti R; Lechat P; Urien S
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):409-16. PubMed ID: 15991041
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients.
Alqahtani S; Alenazi M; Alsultan A; Alsarhani E
Saudi J Kidney Dis Transpl; 2021; 32(1):101-110. PubMed ID: 34145119
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
[TBL] [Abstract][Full Text] [Related]
20. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
Guy-Viterbo V; Baudet H; Elens L; Haufroid V; Lacaille F; Girard M; Debray D; Chardot C; Reding R; Wallemacq P; Musuamba F
Pharmacogenomics; 2014 Jun; 15(9):1207-21. PubMed ID: 25141896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]